InfaCare Pharmaceutical Corporation Announces Formation Of New Product Advisory Board

Published: Jun 07, 2006

PLYMOUTH MEETING, Pa., June 7 /PRNewswire/ -- InfaCare Pharmaceutical, a privately held, pediatric-focused specialty pharmaceutical company, announced today the formation of a New Product Advisory Board to counsel it in its drug development efforts. This world-class advisory group will assist the company in finalizing its drug development strategy, improving the likelihood innovative treatments will become available to address unmet needs of infants and older children.

Back to news